Roth Capital began coverage on shares of Atomera (NASDAQ:ATOM) in a research note released on Thursday, MarketBeat Ratings reports. The firm issued a buy rating and a $8.00 target price on the technology company’s stock.

ATOM has been the subject of several other research reports. Loop Capital initiated coverage on Atomera in a research note on Thursday, June 21st. They issued a buy rating and a $10.00 price target for the company. ValuEngine lowered Atomera from a buy rating to a hold rating in a research note on Thursday, July 19th.

Shares of Atomera stock traded down $0.02 on Thursday, hitting $4.69. The company’s stock had a trading volume of 1,100 shares, compared to its average volume of 117,044. Atomera has a 1 year low of $2.45 and a 1 year high of $8.00.

Atomera (NASDAQ:ATOM) last announced its quarterly earnings results on Thursday, August 9th. The technology company reported ($0.26) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.22 by ($0.48). The company had revenue of $0.10 million during the quarter.

An institutional investor recently bought a new position in Atomera stock. Northern Trust Corp acquired a new position in Atomera Inc (NASDAQ:ATOM) during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 22,129 shares of the technology company’s stock, valued at approximately $138,000. Northern Trust Corp owned about 0.18% of Atomera at the end of the most recent quarter. 15.91% of the stock is owned by institutional investors and hedge funds.

Atomera Company Profile

Atomera Incorporated engages in the business of developing, commercializing, and licensing proprietary processes and technologies for the semiconductor industry. Its lead technology is Mears Silicon Technology, a thin-film of reengineered silicon that can be applied as a transistor channel enhancement to CMOS-type transistors.

Read More: Dollar Cost Averaging

Receive News & Ratings for Atomera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atomera and related companies with MarketBeat.com's FREE daily email newsletter.